로딩 중…
StockDiggingStockDigging

ASTERASYS

450950· KOSDAQ
₩7,300-5.93%
2026-06-19

Price Chart

ASTERASYS-43.15%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap274.68B KRW
Revenue38.72B KRW
Net Income2.36B KRW
Total Assets52.21B KRW
Net Assets44.16B KRW
Employees77
Value
P/E116.50x
P/B6.22x
P/S7.09x
EV/EBITDA211.78x
FCF Yield1.29%
Profitability
ROE5.34%
ROA4.52%
Op. Margin3.32%
Revenue Growth11.67%
Earnings Growth-283.31%
Financial Health
Debt Ratio118.23%
Total Debt1.00B KRW
FCF3.54B KRW
Cash3.06B KRW
Current Ratio5.51x
Net Debt/EBITDA-1.60x
Dividend
Div. Yield1.37%
Div. Growth228.13%
Performance
1Y Return-43.15%
1M Return-20.65%
From 52W High-58.24%
1Y MDD-56.46%
Trading
Volume46,269 shares
Foreign Own.0.47%
Per Share
EPS208 KRW
BPS1,174 KRW

Company Info

CEO 서은택
Employees 77
Founded 2015
HQ 서울특별시 성동구, KR

The company, Asterasys, established in 2015 for medical device manufacturing, is a small and medium-sized venture listed on KOSDAQ in 2025. It manufactures and sells anti-aging skin beauty devices using high-intensity focused ultrasound and non-invasive high-frequency, with Liftera as its main product. By the end of 2023, three new products were developed through KOL collaboration, and Coolfase and Coolsoniq obtained MFDS product approval. The company targets the global market after securing US FDA certification in 2026. Asterasys was established in 2015 and is headquartered in Seongdong-gu, Seoul.